290 likes | 550 Views
Apoptosis – mechanisms and role in cancer therapy. TYPES OF CELL DEATH: Necrotic or apoptotic. APOPTOSIS. External signals. WHEN DOES APOPTOSIS OCCUR?. Normal development e.g. immune system. WHEN DOES APOPTOSIS OCCUR?. Disease states e.g. Alzheimer’s disease. Amyloid plaques in the brain.
E N D
WHEN DOES APOPTOSIS OCCUR? Normal development e.g. immune system
WHEN DOES APOPTOSIS OCCUR? Disease states e.g. Alzheimer’s disease Amyloid plaques in the brain
Caspases – key executioners of apoptosis (cysteinyl aspartate specific proteases) Highly conserved proteases inactive zymogens Caspases divided into Group I Inflammatory caspases Caspases 1,4,5,11,12,13,14 Group II Initiator caspases Caspases 2,8,9,10 Group III Effector caspases: caspases 3,6,7
Properties of proteases • Irreversible - • Autocatalytic: triggered by cofactor binding or inhibitor removal • Proteases can regulate their own activation • protease inhibitors • specificity
Caspase structure 3 domains 1) highly variable NH2 domain 2) large subunit (p20; ~20kD) 3) small subunit ( p10; ~10kD) Highly specific absolute requirement for cleavage after aspartic acid recognition of at least 4 amino acids NH2 terminals to the cleavage site
Caspase structure 2 key features: variable N domain regulates activation all domains derived from proenzyme precursor by cleavage specific sites Scheme of procaspase activation:Cleavage of the procaspase at the specific Asp-X bonds leads to the formation of the mature caspase, which comprises the heterotetramer p202–p102, and the release of the prodomain.
Structure of caspase-3 heterotetramer Each heterodimer is formed by hydrophobic interactions resulting in the formation of mostly parallel ß-sheets, composed of 6 antiparallel ß-strands. Two heterodimers fit together with formation of a 12-stranded ß-sheet that is sandwiched by a helices. N and C termini of the small and large protease subunits are indicated
Basic apoptotic machinery • DNA fragmentation, • chromatin condensation, • membrane blebbing, • cell shrinkage & • disassembly into apoptotic bodies • engulfment Initiator caspases inactivate proteins that protect cells from apoptosis Effector caspases are responsible for cellular changes associated with apoptosis.
How do caspases disassemble a cell? It slices, it dices! Selective cleavage of specific proteins eg bcl-2, or CAD/ICAD e.g. nuclear lamins eg. Gelsolin
What triggers apoptosis? • Growth factor withdrawal • Specific ‘death ligands • Loss of contact with surroundings • Irreparable internal damage • Conflicting signals for cell division
How are caspases activated? Proteolytic cleavage • 2 key features: • variable N domain regulates activation • all domains derived from precursor by cleavage specific sites Cleavage of the procaspase at the specific Asp-X bonds leads to the formation of the mature caspase, which comprises the heterotetramer p202–p102, and the release of the prodomain.
How are caspases activated? Induced proximity aggregation of multiple procaspase-8 molecules into close proximity somehow results in cross-activation
How are caspases activated? Holoenzyme formation Activation of caspase-9 is mediated by means of conformational change, not proteolysis
nematode - C.elegans One of the apoptotic pathways is triggered by internal signals- CED CED-3 & 4 promote apoptosis CED-9 inhibits apoptosis Apoptotic stimuli causes CED-9 dissociation by EGL-1 thereby activating CED-3.
Caspase signaling in Mammalian systems IN Lavrik et al The Journal of Clinical Investigation 115(10):2665-72. (October 2005)
Mammalian systems Mammals
External signals driven by death receptors (DR) e.g. CD95 (or Fas/Apo) Each CD95L trimer binds to 3 CD95 leading to DD clustering. FADD ( Fas associated death domain/ Mort 1) binds via its own DD Caspase –8 oligomerisation drives activation through self cleavage Caspase –8 then activates downstream effector caspases like caspase –9 (CED-9 homolog) Apoptosis initiation
TRIGGER REGULATOR EXECUTIONER P53 Bcl-2 family Cytochrome c oncogenes Apaf-1 Caspases DNA damage Death receptors Growth factor withdrawal
Green and Kroemer The Journal of Clinical Investigation 115(10):2610-17 (October 2005)
References Chapter 12: Cellular & Mol Biologyby Knowles and SelbyAND/ORScience (1998)Vol 281: No 5381; pgs 1298-1326 AND/ORJ. Clin Invest (10 Oct 2005)115(10):2665-72 AND/ORCancer Biology by RJB King pgs 160-167AND/OR NATURE | VOL 407 | 12 OCTOBER 2000 pp770-776 The biochemistry of apoptosis by M.O. Hengartner Optional NATURE REVIEWS MOLECULAR CELL BIOLOGY Vol 5 | NOV 2004 | 897 Molecular mechanisms of caspase regulation during apoptosis Stefan J. Riedl and Yigong Shi (Only read it if you want to know more about caspase structure)